ATRX, DAXX or MEN1 mutant pancreatic neuroendocrine tumors are a distinct alpha-cell signature subgroup
In pancreatic neuroendocrine tumors (PanNETs) ATRX, DAXX, and MEN1 are commonly mutated (A-D-M mutant PanNETs). Here, the authors find in a cohort of PanNETS 58% are A-D-M mutant PanNETs, with a worse clinical outcome and differences in gene expression and methylation compared to A-D-M wild type cas...
Guardado en:
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2018
|
Materias: | |
Acceso en línea: | https://doaj.org/article/91a16d51722c4f0dab5944814d57ad6b |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:91a16d51722c4f0dab5944814d57ad6b |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:91a16d51722c4f0dab5944814d57ad6b2021-12-02T16:56:56ZATRX, DAXX or MEN1 mutant pancreatic neuroendocrine tumors are a distinct alpha-cell signature subgroup10.1038/s41467-018-06498-22041-1723https://doaj.org/article/91a16d51722c4f0dab5944814d57ad6b2018-10-01T00:00:00Zhttps://doi.org/10.1038/s41467-018-06498-2https://doaj.org/toc/2041-1723In pancreatic neuroendocrine tumors (PanNETs) ATRX, DAXX, and MEN1 are commonly mutated (A-D-M mutant PanNETs). Here, the authors find in a cohort of PanNETS 58% are A-D-M mutant PanNETs, with a worse clinical outcome and differences in gene expression and methylation compared to A-D-M wild type cases- these gene expression differences suggest that A-D-M mutant PanNETs potentially originate from a cell type similar to alpha cells.Chang S. ChanSaurabh V. LaddhaPeter W. LewisMatthew S. KoletskyKenneth RobzykEdaise Da SilvaPaula J. TorresBrian R. UntchJanet LiPromita BoseTimothy A. ChanDavid S. KlimstraC. David AllisLaura H. TangNature PortfolioarticleScienceQENNature Communications, Vol 9, Iss 1, Pp 1-10 (2018) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Science Q |
spellingShingle |
Science Q Chang S. Chan Saurabh V. Laddha Peter W. Lewis Matthew S. Koletsky Kenneth Robzyk Edaise Da Silva Paula J. Torres Brian R. Untch Janet Li Promita Bose Timothy A. Chan David S. Klimstra C. David Allis Laura H. Tang ATRX, DAXX or MEN1 mutant pancreatic neuroendocrine tumors are a distinct alpha-cell signature subgroup |
description |
In pancreatic neuroendocrine tumors (PanNETs) ATRX, DAXX, and MEN1 are commonly mutated (A-D-M mutant PanNETs). Here, the authors find in a cohort of PanNETS 58% are A-D-M mutant PanNETs, with a worse clinical outcome and differences in gene expression and methylation compared to A-D-M wild type cases- these gene expression differences suggest that A-D-M mutant PanNETs potentially originate from a cell type similar to alpha cells. |
format |
article |
author |
Chang S. Chan Saurabh V. Laddha Peter W. Lewis Matthew S. Koletsky Kenneth Robzyk Edaise Da Silva Paula J. Torres Brian R. Untch Janet Li Promita Bose Timothy A. Chan David S. Klimstra C. David Allis Laura H. Tang |
author_facet |
Chang S. Chan Saurabh V. Laddha Peter W. Lewis Matthew S. Koletsky Kenneth Robzyk Edaise Da Silva Paula J. Torres Brian R. Untch Janet Li Promita Bose Timothy A. Chan David S. Klimstra C. David Allis Laura H. Tang |
author_sort |
Chang S. Chan |
title |
ATRX, DAXX or MEN1 mutant pancreatic neuroendocrine tumors are a distinct alpha-cell signature subgroup |
title_short |
ATRX, DAXX or MEN1 mutant pancreatic neuroendocrine tumors are a distinct alpha-cell signature subgroup |
title_full |
ATRX, DAXX or MEN1 mutant pancreatic neuroendocrine tumors are a distinct alpha-cell signature subgroup |
title_fullStr |
ATRX, DAXX or MEN1 mutant pancreatic neuroendocrine tumors are a distinct alpha-cell signature subgroup |
title_full_unstemmed |
ATRX, DAXX or MEN1 mutant pancreatic neuroendocrine tumors are a distinct alpha-cell signature subgroup |
title_sort |
atrx, daxx or men1 mutant pancreatic neuroendocrine tumors are a distinct alpha-cell signature subgroup |
publisher |
Nature Portfolio |
publishDate |
2018 |
url |
https://doaj.org/article/91a16d51722c4f0dab5944814d57ad6b |
work_keys_str_mv |
AT changschan atrxdaxxormen1mutantpancreaticneuroendocrinetumorsareadistinctalphacellsignaturesubgroup AT saurabhvladdha atrxdaxxormen1mutantpancreaticneuroendocrinetumorsareadistinctalphacellsignaturesubgroup AT peterwlewis atrxdaxxormen1mutantpancreaticneuroendocrinetumorsareadistinctalphacellsignaturesubgroup AT matthewskoletsky atrxdaxxormen1mutantpancreaticneuroendocrinetumorsareadistinctalphacellsignaturesubgroup AT kennethrobzyk atrxdaxxormen1mutantpancreaticneuroendocrinetumorsareadistinctalphacellsignaturesubgroup AT edaisedasilva atrxdaxxormen1mutantpancreaticneuroendocrinetumorsareadistinctalphacellsignaturesubgroup AT paulajtorres atrxdaxxormen1mutantpancreaticneuroendocrinetumorsareadistinctalphacellsignaturesubgroup AT brianruntch atrxdaxxormen1mutantpancreaticneuroendocrinetumorsareadistinctalphacellsignaturesubgroup AT janetli atrxdaxxormen1mutantpancreaticneuroendocrinetumorsareadistinctalphacellsignaturesubgroup AT promitabose atrxdaxxormen1mutantpancreaticneuroendocrinetumorsareadistinctalphacellsignaturesubgroup AT timothyachan atrxdaxxormen1mutantpancreaticneuroendocrinetumorsareadistinctalphacellsignaturesubgroup AT davidsklimstra atrxdaxxormen1mutantpancreaticneuroendocrinetumorsareadistinctalphacellsignaturesubgroup AT cdavidallis atrxdaxxormen1mutantpancreaticneuroendocrinetumorsareadistinctalphacellsignaturesubgroup AT laurahtang atrxdaxxormen1mutantpancreaticneuroendocrinetumorsareadistinctalphacellsignaturesubgroup |
_version_ |
1718382695190364160 |